ResMed | RMD - Ordinary Share Capital



ResMed reported $146.63M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Ansell USD 1.03B 305.2M Jun/2024
AtriCure USD 49.69M 49.64M Jun/2025
Baxter International USD 683M 0 Dec/2024
Cochlear AUD 1.18B 19.2M Dec/2024
Cooper Companies USD 198.8M 177M Jul/2025
CSL USD 576M 19M Dec/2024
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 654.8M 500K Dec/2024
Fisher Paykel Healthcare NZD 585.9M 121.7M Mar/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Haemonetics USD 48.16M 47.66M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Idexx Laboratories USD 80.42M 63.77M Jun/2025
Insulet USD 70.39M 70.29M Jun/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 358.42M 358.02M Jun/2025
Masimo USD 54.3M 54.2M Jun/2025
Medtronic USD 128K 128K Apr/2025
Philips EUR 950.57M 762.57M Jun/2025
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
ResMed USD 146.63M 145.87M Jun/2025
Sigma Healthcare AUD 1.64B 43.99M Jul/2024
Sonic Healthcare AUD 4.15B 467K Dec/2024
Steris USD 98.37M 4.32B Jun/2025
Teleflex USD 44.19M 4M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025